Users Coming Off Anti-Obesity Injections Gain Back Weight Far More Rapidly Compared to Those on Conventional Diets

Fresh analysis indicates that individuals who come off blockbuster slimming jabs like semaglutide or tirzepatide can put back on reduced body mass at a significantly accelerated pace than those who end conventional lifestyle plans.

Published data in a prominent health publication shows that while obese individuals can lose a large proportion of their total mass while using the jabs, the weight comes back at an average rate of nearly a kilo each month after stopping.

"People purchasing such drugs must be informed of the potential of fast weight regain when the medication concludes," warns lead investigator Dr. Susan Jebb.

This pace of recovery suggests a return to pre-treatment mass in about 18 months.

Analyzing Treatments

The study, which looked at dozens of studies involving thousands of patients, compared the outcomes of these new drugs with conventional dieting.

Researchers note that people who shed pounds through lifestyle changes alone usually have a slower creep back—approximately 0.1 kg a month—after stopping.

Understanding the Fast Regain

Doctors suggest the mechanism of the injections accounts for the accelerated weight return.

These medications copy a natural hormone called GLP-1, which controls hunger.

"Sustained high doses of the hormone concentrations far above than the body's typical production could lead to the system to produce less of its own natural hormone, and could diminish responsiveness to its effects," explained Dr. Adam Collins, a nutrition researcher.

"Discontinuation of this hormone supplement means appetite is no longer kept in check, making overeating far more likely."

A Lifelong Issue?

Medical guidelines recommend the jabs for individuals with weight-linked medical conditions, alongside recommended diet and exercise modifications.

A number of clinicians contend that, due to the likelihood of weight regain, the treatment might need to be long-term.

This view is echoed by pharmaceutical companies, who state that the results "highlight the long-term character of excess weight," comparing it to managing conditions like high blood pressure.

User Accounts

Individuals who have come off the jabs describe a powerful resurgence of appetite.

"I experienced something flipping and you become ravenous," described an individual.

The struggle is exacerbated if users have not developed lasting lifestyle or habit modifications during therapy.

Significant Interest

Figures show that a significant number of adults in the UK have tried weight-loss jabs in the past year, with demand being substantial.

• Use is more common among women than men.
• The 40s and 50s age group shows the greatest level of interest.
• A large proportion access the drugs through private healthcare rather than the NHS.

Finally, clinicians emphasize that while these medications are effective agents for weight loss, they are not a permanent solution and long-term success likely depends on ongoing lifestyle support.